Sun Pharma: Net profit leapfrogs 50% - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma: Net profit leapfrogs 50%

Oct 19, 2001

Sun Pharmaceuticals has posted a growth of 50% in net profit for 2QFY02, compared to the corresponding period last fiscal. Sales have jumped by more than 29% to touch Rs 1,962 m. Operating margins increased by 470 basis points to 27%, which is amongst the best in the industry. The performance of the company has been far above market expectation.

(Rs m)2QFY012QFY02ChangeFY01
Sales 1,519 1,962 29.2% 6,132
Other Income 33 23 -31.5% 67
Expenditure 1,179 1,431 21.3% 4,625
Operating Profit (EBDIT) 340 531 56.3% 1,507
Operating Profit Margin (%)22.4%27.1%24.6%
Interest (6) (11.5)82.5% (21)
Depreciation 35 43 21.0% 152
Profit before Tax344 522.3 52.0% 1,444
Other Adjustments - -
Tax 22 40 83.6% 95
Profit after Tax/(Loss) 322 482 49.8% 1,349
Net profit margin (%)21.2%24.6%22.0%
No. of Shares (eoy) (m) 46.8 46.8 46.8
Diluted Earnings per share*27.5 41.2 28.9
P/E (at current price) 14.0 19.9
*(annualised)

The better than expected performance has been on the back of 130% growth in exports. The growth in exports was helped mainly due to merger with Sun Pharma Exports Ltd. However, even excluding the merger effect, net profit has grew by 35%. In the domestic formulation business, sales grew by 28%, far outperforming industry growth rates. The growth was on the back of a aggressive launch of new products. The company has launched more than 25 new products in last one quarter across various therapeutic segments.

Sun Pharma has informed that Caraco Pharma, the US affiliate of the company expects 2 ANDA (Abbreviated New Drug Application) approvals by the end of the current calendar year. Caraco already has 3 ANDA approvals to its credit. Exports on account of this ANDA could help the Caraco Pharma to come out of red, which remains a major cause for concern.

At Rs 575, the company trades at a P/E multiple of 14x annualised earnings for 2QFY02.

Equitymaster requests your view! Post a comment on "Sun Pharma: Net profit leapfrogs 50%". Click here!

  

More Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This... (Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Apr 13, 2021 03:38 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS